Biologics and complex chemistry will dominate pharma sector over the next 5 years, says Deepak Mallik of Edelweiss

Financial year ended March 31, 2018, was one of the worst years for pharmaceutical companies as the sector saw a 50 percent cut in its earnings. In this episode of The Medicine Box, Ekta Batra talks to Deepak Mallik, research analyst, and associate director, Institutional Equities – Research, Edelweiss on the future of the pharma sector’s earnings. He believes biologics and complex chemistry will dominate the pharma sector over the next 5 years.